ADAPT platform for antibody affinity maturation (T-90201) .: NR16-171/2017E-PDF
“To aid in the selection and rationalization of mutants that improve and/or modulate the affinity of antibodies and other biologics, the NRC has developed an efficient platform called ADAPT (Assisted Design of Antibody and Protein Therapeutics). ADAPT interleaves computational predictions with experimental validation, significantly aiding the design of protein therapeutics by guiding the selection of optimal mutations”--Highlights, p. [1].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847426&sl=0
| Department/Agency | National Research Council Canada. |
|---|---|
| Title | ADAPT platform for antibody affinity maturation (T-90201) . |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Plateforme ADAPT pour la maturation de l’affinité des anticorps (T-90201). Caption title. "December 2017." Issued also in print format. |
| Publishing information | [Ottawa] : National Research Council Canada, [2018] |
| Description | [2] p. : col. ill. |
| ISBN | 9780660239132 |
| Catalogue number |
|
| Subject terms | Immunotechnology |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: